http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111303267-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4716 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate | 2020-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111303267-B |
titleOfInvention | A polypeptide with enhanced NK cell killing activity and its application |
abstract | The present invention provides a polypeptide with enhanced NK cell killing activity and application thereof, belonging to the technical field of life sciences. The amino acid sequence of the polypeptide with enhanced NK cell killing activity is shown in SEQ ID No. 1; After incubation of NK cells, it can significantly enhance the killing activity of NK cells on tumor cells and increase the expression of perforin and CD107a in NK cells. |
priorityDate | 2020-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 235.